Edition:
United States

NewLink Genetics Corp (NLNK.OQ)

NLNK.OQ on NASDAQ Stock Exchange Global Market

6.35USD
18 Aug 2017
Change (% chg)

$-0.09 (-1.40%)
Prev Close
$6.44
Open
$6.37
Day's High
$6.47
Day's Low
$6.26
Volume
70,848
Avg. Vol
226,062
52-wk High
$25.11
52-wk Low
$5.91

NLNK.OQ

Chart for NLNK.OQ

About

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic... (more)

Overall

Beta: 1.36
Market Cap(Mil.): $186.82
Shares Outstanding(Mil.): 29.42
Dividend: --
Yield (%): --

Financials

  NLNK.OQ Industry Sector
P/E (TTM): -- 79.67 32.70
EPS (TTM): -2.29 -- --
ROI: -50.00 2.87 14.88
ROE: -52.94 5.20 16.12

BRIEF-NewLink Genetics Q2 loss per share $0.57

* NewLink Genetics - ‍expect to end 2017 with approximately $75 million in cash and equivalents, which excludes any cash that may be received from financing​

Jul 28 2017

BRIEF-Newlink Genetics ‍receives notice of allowance from USPTO covering indoximod salts and prodrugs​

* Newlink Genetics says ‍receives notice of allowance from USPTO covering indoximod salts and prodrugs​ Source text for Eikon: Further company coverage:

Jul 10 2017

BRIEF-Great Point Partners reports 5.13 pct passive stake in Newlink Genetics

* Great Point Partners reports 5.13 percent passive stake in Newlink Genetics Corp as of May 26 - SEC filing Source text for Eikon: Further company coverage:

Jun 05 2017

BRIEF-Newlink Genetics reports first quarter 2017 financial results

* Newlink Genetics reports first quarter 2017 financial results and updates clinical trial guidance

May 04 2017

BRIEF-Newlink Genetics Q4 loss per share $0.46

* Qtrly total revenue $12.7 million versus. $7.7 million, qtrly loss per share $0.46 Source text for Eikon: Further company coverage:

Feb 28 2017

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,381 -13.00
Pfizer Inc. (PFE.N) $32.67 -0.28
Novartis AG (NOVN.S) CHF79.80 -0.85
Merck & Co., Inc. (MRK.N) $61.49 -0.32
Roche Holding Ltd. (ROG.S) CHF241.40 -2.80
Roche Holding Ltd. (RO.S) CHF244.50 -2.30
Abbott Laboratories (ABT.N) $48.74 -0.55
Sanofi SA (SASY.PA) €82.26 -0.50
AstraZeneca plc (AZN.L) 4,447.00 -34.00
GlaxoSmithKline plc (GSK.L) 1,490.00 -16.00

Earnings vs. Estimates